These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31166004)

  • 1. Roles of organic anion transporter 2 and equilibrative nucleoside transporter 1 in hepatic disposition and antiviral activity of entecavir during non-pregnancy and pregnancy.
    Ma Z; Lu S; Sun D; Bai M; Jiang T; Lin N; Zhou H; Zeng S; Jiang H
    Br J Pharmacol; 2019 Sep; 176(17):3236-3249. PubMed ID: 31166004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human organic anion transporter 2 is an entecavir, but not tenofovir, transporter.
    Furihata T; Morio H; Zhu M; Suzuki Y; Ide H; Tsubota A; Fu Z; Anzai N; Chiba K
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):116-119. PubMed ID: 27916488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple SLC and ABC Transporters Contribute to the Placental Transfer of Entecavir.
    Ma Z; Yang X; Jiang T; Bai M; Zheng C; Zeng S; Sun D; Jiang H
    Drug Metab Dispos; 2017 Mar; 45(3):269-278. PubMed ID: 28062543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ENT1, a ribavirin transporter, plays a pivotal role in antiviral efficacy of ribavirin in a hepatitis C virus replication cell system.
    Iikura M; Furihata T; Mizuguchi M; Nagai M; Ikeda M; Kato N; Tsubota A; Chiba K
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1407-13. PubMed ID: 22232287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycyrrhetic acid, but not glycyrrhizic acid, strengthened entecavir activity by promoting its subcellular distribution in the liver via efflux inhibition.
    Chen Q; Chen H; Wang W; Liu J; Liu W; Ni P; Sang G; Wang G; Zhou F; Zhang J
    Eur J Pharm Sci; 2017 Aug; 106():313-327. PubMed ID: 28627473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic acid transport into human liver involves organic anion transporter 2 (SLC22A7).
    Mathialagan S; Bi YA; Costales C; Kalgutkar AS; Rodrigues AD; Varma MVS
    Biochem Pharmacol; 2020 Apr; 174():113829. PubMed ID: 32001236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus.
    Julander JG; Colonno RJ; Sidwell RW; Morrey JD
    Antiviral Res; 2003 Aug; 59(3):155-61. PubMed ID: 12927305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy Impacts Entecavir Pharmacokinetics but Does Not Alter Its Renal Excretion.
    Lu S; Yang X; Jiang T; Zhou H; Wang W; Lin N; Zeng S; Ma Z; Jiang H
    J Pharm Sci; 2020 May; 109(5):1811-1818. PubMed ID: 32027922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive Influx and Ion Trapping Are More Relevant to the Cellular Accumulation of Highly Permeable Low-Molecular-Weight Acidic Drugs than Is Organic Anion Transporter 2.
    Bednarczyk D
    Drug Metab Dispos; 2021 Aug; 49(8):648-657. PubMed ID: 34031139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Hepatic Organic Anion Transporter 2 in the Pharmacokinetics of R- and S-Warfarin: In Vitro Studies and Mechanistic Evaluation.
    Bi YA; Lin J; Mathialagan S; Tylaska L; Callegari E; Rodrigues AD; Varma MVS
    Mol Pharm; 2018 Mar; 15(3):1284-1295. PubMed ID: 29433307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites.
    Miller SR; McGrath ME; Zorn KM; Ekins S; Wright SH; Cherrington NJ
    Mol Pharmacol; 2021 Dec; 100(6):548-557. PubMed ID: 34503974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMCdG, a Novel Nucleoside Analog with Favorable Safety Features, Exerts Potent Activity against Wild-Type and Entecavir-Resistant Hepatitis B Virus.
    Higashi-Kuwata N; Hayashi S; Das D; Kohgo S; Murakami S; Hattori SI; Imoto S; Venzon DJ; Singh K; Sarafianos SG; Tanaka Y; Mitsuya H
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Drug Transporters Are Involved in Renal Secretion of Entecavir.
    Yang X; Ma Z; Zhou S; Weng Y; Lei H; Zeng S; Li L; Jiang H
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6260-70. PubMed ID: 27503646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hepatitis B virus polymerase by entecavir.
    Langley DR; Walsh AW; Baldick CJ; Eggers BJ; Rose RE; Levine SM; Kapur AJ; Colonno RJ; Tenney DJ
    J Virol; 2007 Apr; 81(8):3992-4001. PubMed ID: 17267485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased liver distribution of entecavir is related to down-regulation of Oat2/Oct1 and up-regulation of Mrp1/2/3/5 in rat liver fibrosis.
    Xu Q; Wang C; Liu Q; Meng Q; Sun H; Peng J; Sun P; Huo X; Liu K
    Eur J Pharm Sci; 2015 Apr; 71():73-9. PubMed ID: 25712368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organic Anion Transporter 2 Mediates Hepatic Uptake of Tolbutamide, a CYP2C9 Probe Drug.
    Bi YA; Mathialagan S; Tylaska L; Fu M; Keefer J; Vildhede A; Costales C; Rodrigues AD; Varma MVS
    J Pharmacol Exp Ther; 2018 Mar; 364(3):390-398. PubMed ID: 29326367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the equilibrative nucleoside transporter 1 on tissue and fetal distribution of ribavirin in the mouse.
    Endres CJ; Moss AM; Ishida K; Govindarajan R; Unadkat JD
    Biopharm Drug Dispos; 2016 Sep; 37(6):336-44. PubMed ID: 27194214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of Hepatic Organic Anion Transport Proteins OAT2 and OAT7 in Human Liver Tissue and Primary Hepatocytes.
    Vildhede A; Kimoto E; Rodrigues AD; Varma MVS
    Mol Pharm; 2018 Aug; 15(8):3227-3235. PubMed ID: 29906129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saturable Hepatic Extraction of Gemcitabine Involves Biphasic Uptake Mediated by Nucleoside Transporters Equilibrative Nucleoside Transporter 1 and 2.
    Shimada T; Nakanishi T; Tajima H; Yamazaki M; Yokono R; Takabayashi M; Shimada T; Sawamoto K; Miyamoto K; Kitagawa H; Ohta T; Tamai I; Sai Y
    J Pharm Sci; 2015 Sep; 104(9):3162-9. PubMed ID: 26037416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Entecavir resistance in entecavir naive lamivudine treated chronic hepatitis B patients].
    Sayan M; Hülagü S; Akhan SC; Sentürk O; Meriç M; Cekmen M
    Mikrobiyol Bul; 2009 Jul; 43(3):425-32. PubMed ID: 19795617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.